CLLS Cellectis

Watchlist

2.550
+0.080+3.24%

Close Apr 19 16:00 ET

183.48MMarket Cap-1536P/E (TTM)

About Cellectis Company

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.

Company Profile

SymbolCLLS

Company NameCellectis

Listing DateMar 25, 2015

Issue Price36.83

Founded1999

CEODr. Andre Choulika

MarketNASDAQ

Employees285

Securities TypeDR

ADS Ratio1.0 : 1.0

Fiscal Year Ends12-31

Address8, rue de la Croix Jarry

CityParis

ProvinceIle-de-France

CountryFrance

Zip Code75013

Phone33-1-81-69-16-00

Websitehttp://www.cellectis.com

Company Executives

Name
Position
Salary

Dr. Andre Choulika
Director and Chief Executive Officer
744.02K

Dr. David Sourdive
Director, Deputy Chief Executive Officer and Executive Vice President, CMC and Manufacturing
528.92K

Stephan Reynier
Chief Regulatory and Pharmaceutical Compliance Officer
--

Philippe Duchateau, PhD
Chief Scientific Officer
--

Kyung Nam-Wortman
Executive Vice President and Chief Human Resources Officer
--

Dr. Mark Frattini, M.D.,PhD
Chief Medical Officer
--

Bing Wang, PhD
Chief Financial Officer
--

Arthur Stril
Chief Business Officer
--

Dr. Steven Doares, PhD
Senior Vice President, US Manufacturing
--

Dr. Jean-Pierre Garnier, PhD
Chairman of the Board
127.44K

Pierre Tristan Michel Bastid
Independent Director
98.80K

Dr. Annick Schwebig
Independent Director
94.85K

Herve Hoppenot
Independent Director
101.75K

Axel-Sven Malkomes
Independent Director
88.26K

Dr. Donald A. Bergstrom, M.D.,PhD
Independent Director
105.68K

Laurent Arthaud
Independent Director
--

Rainer Boehm, M.B.A.,M.D.
Independent Director
87.58K

Marie-Bleuenn Terrier
General Counsel
--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall